List of Clinical Studies


Oncology

Study Name	Sponsor

Alternate approaches for clinical Stage II and III Estrogen receptor positive breast cancer neoadjuvant treatment (ALTERNATE) in postmenopausal women: a Phase III Study	A011106/ CTSU/CIRB

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer	A011401/ CTSU/CIRB

A Phase 3, Randomized, Double-Blind Study of Pembrolizumab plus Ipilimumab vs Pembrolizumab plus Placebo in Previously Untreated, Stage IV, Metastatic Non-small Cell Lung Cancer Subjects Whose Tumors are PD-L1 Positive (TPS = 50%) (KEYNOTE-598)	Merck Sharp & Dohme

A randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin plus Cyclohosphamide followed by weekly Paclitaxel with or without Carboplatin for node-positive ir high-risk Node-negative invasive breast cancer	NRG-BR003/ CTSU/CIRB

Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (veliparib) in metastatic triple-negative Breast Cancer and/or BRCA mutation-associated Breast Cancer	S1416/ CTSU/CIRB

Medical Care